CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: oxybuprocaine
Accession: CHEBI:309594
browse the term
Definition: A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester 'caine') used especially in ophthalmology and otolaryngology.
Synonyms: exact_synonym: 2-(diethylamino)ethyl 4-amino-3-butoxybenzoate
related_synonym: 4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester; 4-Amino-3-n-butoxy-benzoesaeure-diaethylaminoaethylester; Benoxil; Benoxinate; Butoxyaminobenzoyldiethylaminoethanol; Formula=C17H28N2O3; InChI=1S/C17H28N2O3/c1-4-7-11-21-16-13-14(8-9-15(16)18)17(20)22-12-10-19(5-2)6-3/h8-9,13H,4-7,10-12,18H2,1-3H3; InChIKey=CMHHMUWAYWTMGS-UHFFFAOYSA-N; Oxbarukain; Oxibuprokain; Oxybucaine; Oxyriprocaine; SMILES=CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC; oxibuprocaina; oxybuprocainum
xref: Beilstein:2288926; CAS:99-43-4; DrugBank:DB00892; Drug_Central:3016; HMDB:HMDB0015029; KEGG:D08319; LINCS:LSM-2069
xref_mesh: MESH:C005298
xref: PMID:25360701; PMID:3598888; PMID:6621359; PMID:8214534; PMID:9013953; PMID:9989796; Patent:GB654484; Reaxys:2288926; Wikipedia:Oxybuprocaine
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
increases expression
ISO
benoxinate results in increased expression of AIFM1 protein
CTD
PMID:27590991
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
benoxinate results in increased expression of BAX protein
CTD
PMID:27590991
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
benoxinate results in decreased expression of BCL2L1 protein
CTD
PMID:27590991
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Casp2
caspase 2
increases activity
ISO
benoxinate results in increased activity of CASP2 protein
CTD
PMID:27590991
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
G
Casp3
caspase 3
increases activity
ISO
benoxinate results in increased activity of CASP3 protein
CTD
PMID:27590991
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases activity
ISO
benoxinate results in increased activity of CASP9 protein
CTD
PMID:27590991
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
benoxinate results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
benoxinate results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
benoxinate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all